TrialAntimicrobial agents and chemotherapy2014

Genotypic and phenotypic analyses of hepatitis C virus variants observed in clinical studies of VX-222, a nonnucleoside NS5B polymerase inhibitor.

Min Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.